BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1779611)

  • 1. Rapid diagnosis of medium-chain acyl CoA dehydrogenase deficiency by measurement of cis-4-decenoic acid in plasma.
    Heales SJ; Woolf DA; Robinson P; Leonard JV
    J Inherit Metab Dis; 1991; 14(5):661-7. PubMed ID: 1779611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of medium chain acyl CoA dehydrogenase deficiency by measurement of cis-4-decenoic acid in dried blood spots.
    Heales SJ; Leonard JV
    Clin Chim Acta; 1992 Jul; 209(1-2):61-6. PubMed ID: 1395039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cis-4-decenoic acid in plasma: a characteristic metabolite in medium-chain acyl-CoA dehydrogenase deficiency.
    Duran M; Bruinvis L; Ketting D; de Klerk JB; Wadman SK
    Clin Chem; 1988 Mar; 34(3):548-51. PubMed ID: 3349606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population screening for medium-chain acyl-CoA dehydrogenase deficiency: analysis of medium-chain fatty acids and acylglycines in blood spots.
    Bennett MJ; Ragni MC; Ostfeld RJ; Santer R; Schmidt-Sommerfeld E
    Ann Clin Biochem; 1994 Jan; 31 ( Pt 1)():72-7. PubMed ID: 8154855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and quantification of intermediates of unsaturated fatty acid metabolism in plasma of patients with fatty acid oxidation disorders.
    Onkenhout W; Venizelos V; van der Poel PF; van den Heuvel MP; Poorthuis BJ
    Clin Chem; 1995 Oct; 41(10):1467-74. PubMed ID: 7586519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and disposal of medium-chain fatty acids in children with medium-chain acyl-CoA dehydrogenase deficiency.
    Heales SJ; Thompson GN; Massoud AF; Rahman S; Halliday D; Leonard JV
    J Inherit Metab Dis; 1994; 17(1):74-80. PubMed ID: 8051939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of total fatty acids in plasma: cis-5-tetradecenoic acid (C14:1 omega-9) in the diagnosis of long-chain fatty acid oxidation defects.
    Divry P; Vianey-Saban C; Mathieu M
    J Inherit Metab Dis; 1999 May; 22(3):286-8. PubMed ID: 10384388
    [No Abstract]   [Full Text] [Related]  

  • 8. A sensitive and simplified method to analyze free fatty acids in children with mitochondrial beta oxidation disorders using gas chromatography/mass spectrometry and dried blood spots.
    Kimura M; Yoon HR; Wasant P; Takahashi Y; Yamaguchi S
    Clin Chim Acta; 2002 Feb; 316(1-2):117-21. PubMed ID: 11750281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma cis-dec-4-enoic acid measured by isotope dilution mass spectrometry; an improved assay to diagnose medium-chain acyl-CoA dehydrogenase deficiency.
    Johnson DW; Harrison JR; Norton WA; Poulos A; Robertson EF
    J Inherit Metab Dis; 1994; 17(5):554-9. PubMed ID: 7837761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative measurement of total and free 3-hydroxy fatty acids in serum or plasma samples: short-chain 3-hydroxy fatty acids are not esterified.
    Jones PM; Burlina AB; Bennett MJ
    J Inherit Metab Dis; 2000 Nov; 23(7):745-50. PubMed ID: 11117435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma free fatty acids in mitochondrial fatty acid oxidation defects.
    Martínez G; Jiménez-Sánchez G; Divry P; Vianey-Saban C; Riudor E; Rodés M; Briones P; Ribes A
    Clin Chim Acta; 1997 Nov; 267(2):143-54. PubMed ID: 9469249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary medium-chain acylcarnitines in medium-chain acyl-CoA dehydrogenase deficiency, medium-chain triglyceride feeding and valproic acid therapy: sensitivity and specificity of the radioisotopic exchange/high performance liquid chromatography method.
    Schmidt-Sommerfeld E; Penn D; Rinaldo P; Kossak D; Li BU; Huang ZH; Gage DA
    Pediatr Res; 1992 Jun; 31(6):545-51. PubMed ID: 1635814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety of Lipistart, a medium-chain triglyceride based formula, in the dietary treatment of long-chain fatty acid disorders: a phase I study.
    MacDonald A; Webster R; Whitlock M; Gerrard A; Daly A; Preece MA; Evans S; Ashmore C; Chakrapani A; Vijay S; Santra S
    J Pediatr Endocrinol Metab; 2018 Mar; 31(3):297-304. PubMed ID: 29425111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous analysis of plasma free fatty acids and their 3-hydroxy analogs in fatty acid beta-oxidation disorders.
    Costa CG; Dorland L; Holwerda U; de Almeida IT; Poll-The BT; Jakobs C; Duran M
    Clin Chem; 1998 Mar; 44(3):463-71. PubMed ID: 9510849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical diagnosis of fatty acid oxidation disorders by metabolite analysis of postmortem liver.
    Boles RG; Martin SK; Blitzer MG; Rinaldo P
    Hum Pathol; 1994 Aug; 25(8):735-41. PubMed ID: 8056418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of 3-hydroxy-fatty acids in the culture medium of long-chain L-3-hydroxyacyl CoA dehydrogenase (LCHAD) and mitochondrial trifunctional protein-deficient skin fibroblasts: implications for medium chain triglyceride dietary treatment of LCHAD deficiency.
    Jones PM; Butt Y; Bennett MJ
    Pediatr Res; 2003 May; 53(5):783-7. PubMed ID: 12621125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability in the clinical management of fatty acid oxidation disorders: results of a survey of Canadian metabolic physicians.
    Potter BK; Little J; Chakraborty P; Kronick JB; Evans J; Frei J; Sutherland SC; Wilson K; Wilson BJ
    J Inherit Metab Dis; 2012 Jan; 35(1):115-23. PubMed ID: 21630065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial fatty acid beta-oxidation in the human eye and brain: implications for the retinopathy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
    Tyni T; Paetau A; Strauss AW; Middleton B; Kivelä T
    Pediatr Res; 2004 Nov; 56(5):744-50. PubMed ID: 15347768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel tandem mass spectrometry method for rapid confirmation of medium- and very long-chain acyl-CoA dehydrogenase deficiency in newborns.
    ter Veld F; Mueller M; Kramer S; Haussmann U; Herebian D; Mayatepek E; Laryea MD; Primassin S; Spiekerkoetter U
    PLoS One; 2009 Jul; 4(7):e6449. PubMed ID: 19649258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemical characterization of variant medium-chain acyl-CoA dehydrogenase in fibroblasts from patients with medium-chain acyl-CoA dehydrogenase deficiency.
    Coates PM; Indo Y; Young D; Hale DE; Tanaka K
    Pediatr Res; 1992 Jan; 31(1):34-8. PubMed ID: 1594327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.